Pemetrexed for the maintenance treatment of non-small-cell lung cancer

Lung cancer (non-small-cell) - pemetrexed (maintenance): review decision - December 2014 information

Lung cancer (non-small-cell) - pemetrexed (maintenance): appendix A - GE decision paper - December 2014

Lung cancer (non-small-cell) - pemetrexed (maintenance): appendix A - GE decision paper - December 2014 (PDF 496 KB)

Lung cancer (non-small-cell) - pemetrexed (maintenance): review proposal october 2014 information

Lung cancer (non-small-cell) - pemetrexed (maintenance): appendix a - provisional matrix of stakeholders

Lung cancer (non-small-cell) - pemetrexed (maintenance): appendix a - provisional matrix of stakeholders (PDF 100 KB)

Lung cancer (non-small-cell) - pemetrexed (maintenance): appendix b - proposal paper presented to the Institute's Guidance Executive

Lung cancer (non-small-cell) - pemetrexed (maintenance): appendix b - proposal paper presented to the Institute's Guidance Executive (PDF 365 KB)

Lung cancer (non-small-cell) - pemetrexed (mainenance): final appraisal determination information

Lung cancer (non-small-cell) - pemetrexed (mainenance): final appraisal determination

Lung cancer (non-small-cell) - pemetrexed (mainenance): final appraisal determination (PDF 111 KB)

Lung cancer (non-small-cell) - pemetrexed (mainenance): response to consultee, commentator and public comments on the ACD and comments from website consultation

Lung cancer (non-small-cell) - pemetrexed (mainenance): response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 43 KB)

Lung cancer (non-small-cell) - pemetrexed (maintenance): consultee and commentator comments on the ACD

Comments by ERG on additional economic results presented by Eli Lilly

Comments by ERG on additional economic results presented by Eli Lilly (PDF 49 KB)

Manufacturer/sponsor: Eli Lilly

Manufacturer/sponsor: Eli Lilly (PDF 85 KB)

Professional and patient groups

Royal College of Physicians

Royal College of Physicians (PDF 11 KB)

British Thoracic Society

Lung cancer (non-small-cell) - pemetrexed (maintenance): appraisal consultation document

Lung cancer (non-small-cell) - pemetrexed (maintenance): appraisal consultation document information

Evaluation report

Pre-meeting briefing

Pre-meeting briefing (PDF 180 KB)

Evidence Review Group report

Evidence Review Group report (PDF 701 KB)

Factual Accuracy Check

Factual Accuracy Check (PDF 94 KB)

Clarification

Clarification

Clarification (PDF 155 KB)

NICE clarification letter

NICE clarification letter (PDF 36 KB)

Non-manufacturer submissions

Roy Castle Lung Cancer Foundation

Roy Castle Lung Cancer Foundation (PDF 39 KB)

British Thoracic Society

British Thoracic Society (PDF 29 KB)

Royal College of Pathologists

Royal College of Pathologists (PDF 31 KB)

Royal College of Nursing

Royal College of Nursing (PDF 31 KB)

Eli Lilly & Co

Lung cancer (non-small-cell) - pemetrexed (maintenance): final scope

Lung cancer (non-small-cell) - pemetrexed (maintenance): response to consultee and commentator comments on the draft scope

Lung cancer (non-small-cell) - pemetrexed (maintenance): response to consultee and commentator comments on the draft matrix